Fideuram Asset Management (Ireland)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Buy
+13,094
New +$2.5M 0.05% 429
2026
Q1
– Sell
-126
Closed -$18.8K – 486
2025
Q4
$18.8K Buy
+126
New +$20.6K ﹤0.01% 469

Other funds holding BIIB

Fideuram Asset Management (Ireland)'s BIIB Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) opened a new position in Biogen (BIIB) in Q2 2026: 13,094 shares worth $2.74M. The stake represents 0.05% of the portfolio and ranks #429 among its holdings. This is a return to the name: Fideuram Asset Management (Ireland) previously reported a position in BIIB as recently as Q4 2025.

Fideuram Asset Management (Ireland) first reported a position in BIIB in Q4 2025 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 13,094 shares of Biogen worth $2.74M as of Q2 2026.
  • Biogen was a new Fideuram Asset Management (Ireland) position in Q2 2026.
  • Biogen made up 0.05% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #429 holding.
  • Fideuram Asset Management (Ireland) first reported a position in Biogen in Q4 2025 and has held it in 2 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.